2 Pharmaceutical Stocks to Buy and Hold for the Next 10 Years
StockNews
Published Aug 02, 2021 12:02PM ET
Updated Aug 02, 2021 01:30PM ET
2 Pharmaceutical Stocks to Buy and Hold for the Next 10 Years
With the resurgence of COVID-19 cases, the pharmaceutical sector is expected to attract significant investor attention in the coming months as the demand for vaccines and treatment continues to soar. Also, the rising demand for medicines and therapies for treating several critical diseases (other than COVID-19) is likely to propel the industry's growth further. Given the pharmaceutical industry’s tremendous growth potential, we believe established players in this space, Pfizer (PFE) and Eli Lilly (LLY), could be ideal buy-and-hold stocks for the next decade. Let's discuss. As the COVID-19 Delta variant continues its rapid spread, COVID-19 cases are resurfacing in the United States, which has dragged the pharma sector back to center stage. As several countries continue to prioritize the vaccination of their populations to fight the coming new strains of the COVID-19 virus, pharmaceutical companies are now again focused on ramping up their vaccine production to meet the growing demand.
But the increasing prevalence of chronic diseases throughout the world is also expected to drive the demand for pharma products. Furthermore, the digital revolution in providing life-transforming treatments to patients and increasing investments in R&D to develop efficient drugs to fight various critical health conditions are expected to be the major growth drivers of pharmaceutical companies. Consequently, the global pharmaceuticals market is expected to hit $1,700.97 billion in 2025, registering an 8% CAGR
Given this backdrop, shares of leading pharmaceutical companies with resilient business models—Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY)—hold solid upside potential. So, we believe these two stocks could be solid buy-and-hold bets for the next 10 years.
Continue reading on StockNews
Get The News You Want
Written By: StockNews
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.